What is a fair fractional CRO equity grant in 2027?

Direct Answer

There is no single "right" number for a fractional CRO equity grant because the variables shift dramatically between a pre-revenue startup and a $5M ARR growth-stage company. In 2027, the market has settled into a pattern where equity grants are smaller than those for full-time CROs (who might get 3–7% at seed stage) but still meaningful enough to create genuine ownership alignment. A typical range is 0.5% to 3.0% fully diluted, with vesting over 3–4 years and a one-year cliff. The cash component is lower than a full-time role, but the equity should feel real—if it doesn't, you're likely under-granting and will struggle to retain top talent.

Why Equity Matters for Fractional CROs

Fractional CROs in 2027 are not freelancers; they are senior executives who choose to work across multiple companies for variety, leverage, and portfolio diversification. They bring the same strategic depth as a full-time CRO—sales process design, hiring and coaching, forecasting rigor, and board-level reporting—but on a compressed schedule. Equity aligns their incentives with yours: if they help you grow ARR from $1M to $5M, they should benefit directly from that increase in enterprise value.

The key difference from full-time equity grants is scope. A full-time CRO owns the entire revenue function end-to-end. A fractional CRO typically focuses on the highest-leverage activities: building the sales playbook, hiring the first few reps, setting up CRM and revenue operations, and coaching the founder on deal execution. The equity grant should reflect that narrower scope—but not so narrow that the executive feels like a mercenary rather than a partner.

How Stage Drives the Grant Size

Pre-revenue / Seed stage (0–$500K ARR): The fractional CRO is often the first revenue leader. Equity grants here are higher (1.5%–3.0%) because cash is tight and the risk is highest. You're asking someone to validate your product-market fit and build a repeatable sales motion. Expect a 3–4 year vest with a 1-year cliff. Cash might be as low as $3,000–$6,000/month.

Growth stage ($1M–$5M ARR): The company has some traction, so risk is lower. Equity grants drop to 0.25%–1.0%. Cash rises to $6,000–$12,000/month. The fractional CRO is optimizing an existing process—improving conversion rates, professionalizing forecasting, and scaling the team. The equity should still be meaningful (think $50K–$200K in potential value at a reasonable exit).

Scale stage ($5M+ ARR): At this point, you likely need a full-time CRO. But if you use a fractional CRO for a specific project (e.g., entering a new market or fixing a broken sales channel), equity is typically 0.1%–0.5% with a shorter vest (2 years). Cash dominates the compensation.

Cash vs. Equity Tradeoffs

The fractional CRO market in 2027 has a clear spectrum:

• Cash-heavy, equity-light: $10,000–$15,000/month, 0.1%–0.3% equity. Attracts executives who value liquidity and have a full client roster.
• Balanced: $5,000–$8,000/month, 0.5%–1.5% equity. Most common for growth-stage companies. The executive is taking some risk but gets meaningful upside.
• Equity-heavy, cash-light: $3,000–$5,000/month, 2.0%–3.0% equity. Works for early-stage startups where the founder needs deep expertise but can't pay market cash rates.

Common Pitfalls to Avoid

Over-granting early: Giving 3% equity to a fractional CRO who works 10 days/month can create cap table problems later. Founders often regret this when raising Series A. Use a 409A valuation and model dilution scenarios before committing.

Under-granting and losing talent: A 0.1% grant at a $2M ARR company with a $10M valuation is only $10K in paper value. That won't motivate a seasoned executive. If you can't offer meaningful equity, pay higher cash or consider a performance-based bonus tied to ARR growth.

Ignoring vesting acceleration: Standard is single-trigger acceleration (if you fire without cause, unvested shares accelerate). Some fractional CROs ask for double-trigger (acceleration also on change of control). This is negotiable but be prepared to discuss it.

How to Structure the Grant

Most fractional CRO equity grants in 2027 follow this template:

• Type: Incentive Stock Options (ISOs) or Non-Qualified Stock Options (NSOs). ISOs are better for the executive (tax advantages) but limited to $100K vesting per year. NSOs are more common for fractional roles.
• Vesting: 4-year schedule with a 1-year cliff. Some companies use 3-year vesting for shorter engagements.
• Exercise price: Fair market value per 409A. At early stage, this is usually par value ($0.0001–$0.01 per share).
• Expiration: 10 years from grant date.
• Change of control: Single-trigger acceleration of unvested shares is standard. Double-trigger is becoming more common for fractional executives.

FAQ

What if the fractional CRO wants more equity than I'm offering? Negotiate by adjusting cash or time commitment. If they want 2% but you're offering 1%, consider increasing cash by $2,000/month or reducing days from 15 to 10. The goal is a total compensation package that feels fair to both sides.

Should I include a repurchase right for the equity? Yes. Include a right of first refusal and a repurchase option at fair market value if the engagement ends. This prevents a former fractional CRO from holding illiquid shares indefinitely.

How does this compare to a fractional VP of Sales? A fractional VP of Sales typically gets 0.1%–0.5% equity and $8,000–$15,000/month cash. The CRO role is more strategic (owning the entire revenue engine vs. just sales execution), so equity is 2–3x higher for the same time commitment.

Can I give equity in a different class of shares? Sometimes. Founders occasionally offer profit interest units (PIUs) in an LLC or restricted stock in a corporation. These can be tax-advantaged but require legal documentation. Consult your attorney.

What happens if the company doesn't exit or IPO? The equity may be worthless. That's the risk. To mitigate, some fractional CROs negotiate a cash-out option after 5 years if no liquidity event occurs, typically at fair market value. This is rare but becoming more common.

Is 0.5% equity worth it for a fractional CRO? It depends on the company's valuation and growth trajectory. At a $10M valuation, 0.5% is $50,000 in paper value. If you believe the company will 10x in 5 years, that's $500,000. For a 2-year engagement, that's a strong return. But if the company stagnates, it's nothing. Evaluate the risk-reward honestly with the executive.

Sources

• Pavilion - Community for revenue leaders
• RevOps Co-op - Revenue operations best practices
• Harvard Business Review - Executive compensation research
• First Round Review - Startup equity guides
• SaaStr - SaaS fundraising and hiring benchmarks
• LinkedIn - Professional network for executive compensation discussions

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost